Blog
About

10
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Topical immunotherapy with diphencyprone (DPCP) for in-transit and unresectable cutaneous melanoma lesions: an inaugural Canadian series.

      Read this article at

      ScienceOpenPublisherPubMed
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Diphencycprone (DPCP) is an immune contact sensitizer applied to melanoma lesions. Early studies show favorable efficacy. We present the first North-American series of patients treated with DPCP.

          Related collections

          Author and article information

          Journal
          Expert Rev Clin Immunol
          Expert review of clinical immunology
          Informa UK Limited
          1744-8409
          1744-666X
          Apr 2017
          : 13
          : 4
          Affiliations
          [1 ] a Division of Medical Oncology , University of Toronto , Toronto , ON , Canada.
          [2 ] b Division of Medical Oncology , Sunnybrook Health Sciences Centre , Toronto , ON , Canada.
          [3 ] c Division of Surgical Oncology, Sunnybrook Health Sciences Centre , University of Toronto , Toronto , ON , Canada.
          [4 ] d Division of Dermatology , University of Toronto , Toronto , ON , Canada.
          Article
          10.1080/1744666X.2017.1286984
          28121191

          Comments

          Comment on this article